Skip to Main Content
It looks like you're using Internet Explorer 11 or older. This website works best with modern browsers such as the latest versions of Chrome, Firefox, Safari, and Edge. If you continue with this browser, you may see unexpected results.

COVID-19 Research Guide

Tulane researchers in the School of Public Health and Tropical Medicine, School of Medicine, National Primate Research Center, and Science and Engineering are addressing the disease on several fronts

Medical Countermeasures

FDA-regulated products (biologics, drugs, devices) that may be used in the event of a potential public health emergency

Biomedical Advanced Research and Development Authority (BARDA)

Biomedical Advanced Research and Development Authority (BARDA), part of the HHS Office of the Assistant Secretary for Preparedness and Response, was established to aid in securing our nation from chemical, biological, radiological, and nuclear (CBRN) threats, as well as from pandemic influenza (PI) and emerging infectious diseases (EID)

Louisiana Infectious Disease Research

The NIH-NCRR-supported Center of Biomedical Research Excellence (COBRE) was established in 2004 as a strategic alliance between LSU Baton Rouge (flagship campus of the LSU System) and the Tulane National Primate Research Center (TNPRC). The overall vision of the Center has been to establish a regional center in infectious disease research led by the LSU School of Veterinary Medicine (SVM) collaborating and influenced by the substantial NIH investment in infectious disease research carried out at TNPRC

Tulane Expert: Robert F. Garry, Jr., PhD, Professor in the School of Medicine: Virology,

Dr. Garry is currently managing a consortium of scientists who are developing countermeasures, including diagnostics, immunotherapeutics and vaccines, against Lassa virus, Ebola and Marburg viruses, and other high consequence pathogens

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.